Entries by admin
Children’s Hospital Of Los Angeles Passages Program Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease
Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease SOUTH SAN FRANCISCO, Calif. – January 17, 2017 – Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced enrollment of the first patient in the HOPE (Hemoglobin Oxygen Affinity Modulation to Inhibit HbS PolymErization) Study, a pivotal Phase […]
Global Blood Therapeutics (GBT), Inc. Community Q & A Document
Global Blood Therapeutics (GBT), Inc. is a biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat blood-based disorders with significant unmet need. Our most advanced program, GBT440, is in development as a once-daily therapy taken by mouth for sickle cell disease. At GBT, we are committed to advancing the science and transforming […]
WEBINAR – Creating a New SCD Clinic: A Case Study. Register Now: Jan. 25
Sickle Cell Data Collection The California Rare Disease Surveillance Program invites you to attend a webinar, Creating a New SCD Clinic: A Case Study, to find out how a few dedicated professionals created a new county clinic in South Los Angeles, uniquely qualified to serve the population that needed its services the most. Doctors, public health and patient advocates […]